載入錯誤
看來載入頁面時發生了錯誤.
重新載入
我們的團隊已收到通知,但若此問題持續,請透過
電郵支援widget工具
聯絡我們。
524494
5.8%
500257
4.2%
524715
3.3%
HK
前往
登入
觀察名單
觀點
ProPicks AI
篩選器
數據瀏覽
圖表
已儲存工作
收起
GSK Pharmaceuticals
NSEI:GLAXO
印度 / 保健 / 製藥
貨幣
₹
加入觀察名單
綜觀
股息
財報
模型
財務狀況
比較
穩健度
圖表
DDM 多階段
股價
2,750.20
INR
公允價值
1,882.86
INR
Metrics
Range
Conclusion
Perpetuity Growth Rate
4.8% - 5.3%
5.0%
Discount Rate
8.9% - 7.9%
8.4%
Fair Value
₹1,559 - ₹2,393
₹1,883
Upside
-43.9% - -13.8%
-32.2%
32
Current Dividend per Share
1.2%
Current Dividend Yield
37.1%
3yr Avg Div Growth
NM
Ytd Div Growth
Dividend Discount Model: Multi Stage
分享
儲存
股價
2,750.20
INR
公允價值
1,882.86
INR
看漲
-32.2%
Project Adj Dividends
Perpetuity Growth Rate
Fair Value
Project Adjusted Dividends
Fiscal Year Ending
(INR in millions)
Mar-24
Mar-25
Mar-26
Mar-27
Mar-28
Mar-29
Terminal
Net Income to Common
5,900
8,888
10,022
11,470
12,729
13,175
13,175
% Growth
-2.9%
50.7%
12.8%
14.4%
11.0%
3.5%
Payout Ratio
91.8%
90.0%
90.0%
90.0%
90.0%
90.0%
92.5%
Projected Dividends
5,416
7,999
9,020
10,323
11,456
11,857
12,187
% Growth
47.7%
12.8%
14.4%
11.0%
3.5%
支援算式
Historical Performance
Discounting Periods
Discounting Factors
Pv of Discrete Dividends
Pv of Terminal Dividends
Historical Performance
Fiscal Year Ending
YTD
YTD
(INR in millions)
Mar-20
Mar-21
Mar-22
Mar-23
Mar-24
Dec-23
Dec-24
Cash Dividends Paid
3,388
6,770
5,066
15,255
5,416
0
0
% Growth
100%
-25%
201%
-64%
NM
Net Income to Common
932
2,873
3,808
6,076
5,900
3,955
6,647
% Growth
208%
33%
60%
-3%
68%
Payout Ratio
364%
236%
133%
251%
92%
0%
0%
Retention Ratio
-264%
-136%
-33%
-151%
8%
100%
100%
Adjusted EBITDA
6,429
5,733
7,428
7,884
8,805
6,298
8,233
% Growth
-11%
30%
6%
12%
31%
Total Debt
418
346
201
155
187
214
148
Shareholder's Equity
18,206
14,783
26,630
17,413
17,776
15,396
16,727
Debt / EBITDA
0.1
0.1
0.0
0.0
0.0
0.0
Debt / Equity
2%
2%
1%
1%
1%
1%
1%
3-Yr Avg. Dividend Growth
37.1%
5-Yr Median Payout Ratio
235.7%
版權所有。
使用條款
繁體中文
English (UK)
English (India)
English (Canada)
English (Australia)
English (South Africa)
English (Philippines)
Deutsch
Español (España)
Español (México)
Français
Italiano
Nederlands
Português (Portugal)
Polski
Português (Brasil)
Русский
Türkçe
Ελληνικά
Svenska
Suomi
日本語
한국어
简体中文
Bahasa Indonesia
Bahasa Melayu
ไทย
Tiếng Việt
हिंदी